CoChat

The challenge and promise of anti-epileptic therapy development in animal models

Open access
Simonato, Michele, Brooks-Kayal, Amy R, Engel, Jerome, Galanopoulou, Aristea S, Jensen, Frances E, Moshé, Solomon L, O'Brien, Terence J, Pitkanen, Asla, Wilcox, Karen S, French, Jacqueline A · 2014 · The Lancet Neurology
Cited by 114

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Translation of successful target and compound validation studies into clinically effective therapies is a major challenge, with potential for costly clinical trial failures. This situation holds true for the epilepsies—complex diseases with different causes and symptoms. Although the availability of predictive animal models has led to the development of effective antiseizure therapies that are routinely used in clinical practice, showing that translation can be successful, several important unmet therapeutic needs still exist. Available treatments do not fully control seizures in a third of patients with epilepsy, and produce substantial side-effects. No treatment can prevent the development of epilepsy in at-risk patients or cure patients with epilepsy. And no specific treatment for epilepsy-associated comorbidities exists. To meet these demands, a redesign of translational approaches is urgently needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(14)70076-6

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 114

Metadata

Authors
Simonato, M., Brooks-Kayal, A. R., Engel, J., Galanopoulou, A. S., Jensen, F. E., Moshé, S. L., O'Brien, T. J., Pitkanen, A., Wilcox, K. S., & French, J. A.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2014-09
Volume
13
Issue
9
Pages
949-960
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2138234506
Cited by
114
References
9
FWCI
10.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The challenge and promise of anti-epileptic therapy development in animal models. https://app.cochat.ai/papers/10.1016/s1474-4422(14)70076-6
The paper
Simonato, M., Brooks-Kayal, A. R., Engel, J., Galanopoulou, A. S., Jensen, F. E., Moshé, S. L., O'Brien, T. J., Pitkanen, A., Wilcox, K. S., & French, J. A. (2014). The challenge and promise of anti-epileptic therapy development in animal models. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70076-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.